New guidelines for the management of HIV-related opportunistic infections

JAMA

Volumn 301, Issue 22, 2009, Pages 2378-2380

  Masur, Henry ^b   Kaplan, Jonathan E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; NITAZOXANIDE; POSACONAZOLE; RIFAXIMIN; SULFANILAMIDE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CRYOTOCOCCAL; CRYPTOCOCCAL MENINGITIS; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNIZATION; INFECTION PREVENTION; NOTE; OPPORTUNISTIC INFECTION; PATIENT ASSESSMENT; PATIENT INFORMATION; PATIENT MONITORING; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; TOXOPLASMOSIS; AIDS RELATED COMPLEX; ARTICLE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 67049087067     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.865     Document Type: Note

References (14)

1. Centers for Disease Control (CDC). Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1989;38(suppl 5):1-9.
2. Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus: Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. N Engl J Med. 1993;329(12):898-904.
3. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Recomm Rep. 1995;44(RR-8):1-34.
4. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: USPHS/IDSA Prevention of Opportunistic Infections Working Group. MMWR Recomm Rep. 1997;46 (RR-12):1-46.
5. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). MMWR Recomm Rep. 1999;48(RR-10):1-59, 61-66.
6. Kaplan JE, Masur H, Holmes KK, et al. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002: recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-8):1-46.
7. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK; CDC; National Institutes of Health; Infectious Diseases Society of America. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep. 2004;53(RR-15):1-112.
8. Mofenson LM, Oleske J, Serchuck L, Van Dyke R, Wilfert C; CDC; National Institutes of Health; Infectious Diseases Society of America. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Recomm Rep. 2004;53(RR-14):1-92.
9. The Henry J. Kaiser Family Foundation. HIV/AIDS Policy Fact Sheet, July 2007. http://www.kff.org. Accessed November 17, 2008.
10. Hall HI, Song R, Rhodes P, et al; HIV Incidence Surveillance Group. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520-529.
11. Centers for Disease Control and Prevention (CDC). Late versus early testing of HIV-16 sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52(25):581-586.
12. District of Columbia Department of Health. District of Columbia HIV/AIDS Epidemiology Annual Report, 2007. http://www.dchealth.dc.gov/doh/frames .asp?doc=/doh/lib/doh/services/administration-offices/hiv-aids/pdf /epidemiology-annual-2007.pdf. Accessed November 17, 2008.
13. AIDSInfo Web site. Guidelines for Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children-June 20, 2008. http://aidsinfo.nih.gov/contentfiles/Pediatric-OI.pdf. Accessed November 17, 2008.
14. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1-207.